Skip to content
Clinical Trials – home
LithuaniaBack to Lithuania

Clinical trials in Klaipeda – page 2

61 clinical trials in Klaipeda, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.

LithuaniaOur site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)
Klaipeda at a glance
61
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

61 trials in Klaipeda

Open in trial search

Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Micurx Pharmaceuticals Inc.

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Dr Reddy's Laboratories Limited

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:CRD-4730
  • Sponsor:Cardurion Pharmaceuticals Inc.

Prostate cancer

Not yet recruiting

Study on Teverelix for Patients with Advanced Prostate Cancer

InvestigationalNo placebo
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Teverelix
  • Sponsor:Antev Limited

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Human IgG1 kappa monoclonal antibody against CRLF2
  • Sponsor:Upstream Bio Inc.

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Psoriatic arthropathy

Not recruiting

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Other cities in Lithuania

The busiest research cities in the country

All 10 cities in Lithuania

Clinical research in Klaipeda

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on systemic sclerosis, psoriatic arthritis, and ulcerative colitis. Studies are evaluating novel therapies including efgartigimod and sonelokimab to improve patient outcomes.

  • Skin sclerosis treatment
  • Joint inflammation management
  • Gastrointestinal disorders

These trials aim to develop more effective treatments for chronic inflammatory conditions affecting multiple body systems.

02 Neurological Disorders

Groundbreaking studies in multiple sclerosis treatment, particularly focusing on relapsing-remitting forms. Research includes comparative studies of new biologics and established treatments.

  • Brain lesion reduction
  • Disease progression management
  • Long-term treatment efficacy

Clinical trials are exploring innovative approaches to improve neurological function and quality of life.

03 Cardiovascular Research

Studies targeting heart failure and atherosclerotic cardiovascular disease, with emphasis on preventing major adverse cardiac events and improving heart function.

  • Stroke prevention
  • Heart failure management
  • Cardiovascular risk reduction

Research focuses on both preventive measures and treatment of established cardiovascular conditions.

04 Oncology Studies

Advanced research in prostate cancer and bladder cancer, evaluating new treatment approaches including targeted therapies and hormone treatments.

  • Non-invasive cancer treatments
  • Metastatic disease management
  • Novel therapeutic approaches

Trials aim to improve survival rates and quality of life for cancer patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.